McPherson's (ASX:MCP) - Stock Price, News & Analysis

MCP Stock Overview

Provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. More details

MCP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 54.8% below our estimate of its fair value

Risk Analysis

Earnings have declined by 65.3% per year over past 5 years

Does not have a meaningful market cap (A$55M)

McPherson's Limited Competitors

BWX

ASX:BWX

AU$40.0m

Star Combo Pharma

ASX:S66

AU$16.2m

Elixinol Wellness

ASX:EXL

AU$7.8m

Calmer Co International

ASX:CCO

AU$17.6m

Price History & Performance

Summary of all time highs, changes and price drops for McPherson's
Historical stock prices
Current Share Price	AU$0.39
52 Week High	AU$0.67
52 Week Low	AU$0.37
Beta	0.75
11 Month Change	-3.75%
3 Month Change	-16.76%
1 Year Change	-1.28%
33 Year Change	-57.92%
5 Year Change	-84.09%
Change since IPO	-73.26%

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

Aug 01

Recent updates

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

Aug 01

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Dec 18

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

May 17

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

Feb 12

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 25

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

Jan 07

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Dec 20

Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts Dramatically

Dec 03

Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend Yield

Nov 22

Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?

Sep 10

Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks Like

Aug 19

McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up Surprises

Jul 30

Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 15

Shareholder Returns

	MCP	AU Personal Products	AU Market
7D	-1.9%	-7.6%	0.9%
1Y	-1.3%	54.1%	18.4%

Return vs Industry: MCP underperformed the Australian Personal Products industry which returned 54.5% over the past year.

Return vs Market: MCP underperformed the Australian Market which returned 17.7% over the past year.

Price Volatility

Is MCP's price volatile compared to industry and market?
MCP volatility
MCP Average Weekly Movement	6.2%
Personal Products Industry Average Movement	5.6%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.3%

Stable Share Price: MCP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: MCP's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1860	n/a	Brett Charlton	www.mcphersons.com.au

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. The company offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as fragrance and nutrition. It sells its products primarily under the brands, including Dr. LeWinn’s, A’kin, Manicare, Lady Jayne, Swisspers, Fusion Health, Oriental Botanicals, Maseur, Glam by Manicare, Revitanail, Footcare by Maseur, and Stratton.

McPherson's Limited Fundamentals Summary

How do McPherson's's earnings and revenue compare to its market cap?
MCP fundamental statistics
Market cap	AU$55.42m
Earnings (TTM)	-AU$11.39m
Revenue (TTM)	AU$144.65m

0.4x

P/S Ratio

-4.9x

P/E Ratio

Is MCP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCP income statement (TTM)
Revenue	AU$144.65m
Cost of Revenue	AU$68.08m
Gross Profit	AU$76.58m
Other Expenses	AU$87.96m
Earnings	-AU$11.39m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.079
Gross Margin	52.94%
Net Profit Margin	-7.87%
Debt/Equity Ratio	11.9%

How did MCP perform over the long term?

See historical performance and comparison

MCP Stock Overview

Rewards

Risk Analysis

McPherson's Limited Competitors

ASX:BWX

AU$40.0m

ASX:S66

AU$16.2m

ASX:EXL

AU$7.8m

ASX:CCO

AU$17.6m

Price History & Performance

Recent News & Updates

McPherson's Limited, Annual General Meeting, Nov 27, 2024

New major risk - Revenue and earnings growth

Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)

McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Recent updates

McPherson's Limited, Annual General Meeting, Nov 27, 2024

New major risk - Revenue and earnings growth

Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)

McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding Up

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Price target increased by 25% to AU$0.67

Upcoming dividend of AU$0.02 per share

New minor risk - Share price stability

McPherson's Limited Announces Executive Changes

McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch Up

Here's Why McPherson's (ASX:MCP) Can Manage Its Debt Responsibly

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Price target decreased by 14% to AU$0.54

McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last Year

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Less than half of directors are independent

A Look At The Fair Value Of McPherson's Limited (ASX:MCP)

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Now 22% undervalued after recent price drop

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

Consensus EPS estimates fall by 29%, revenue upgraded

These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably Well

Price target decreased by 7.9% to AU$0.78

Now 24% undervalued after recent price drop

First half 2023 earnings: EPS misses analyst expectations

Price target decreased by 11% to AU$0.84

Now 23% undervalued after recent price drop

McPherson's Limited Appoints Linda Gough as Company Secretary

Price target decreased to AU$0.84

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

Consensus forecasts updated

McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022

McPherson's Limited, Annual General Meeting, Nov 22, 2022

Upcoming dividend of AU$0.02 per share

Full year 2022 earnings: EPS misses analyst expectations

McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022

McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Mcpherson's Limited Announces Board Changes

McPherson's Limited Announces Changes to Its Board

McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022

Price target decreased to AU$1.19

Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.

Price target increased to AU$1.53

Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.

McPherson's Limited Provides Earnings Guidance for the Full Year 2021

McPherson's Limited Not Providing Earnings Guidance Due to COVID-19

McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board

Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?

McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021

Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?

Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?

A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)

Investor sentiment improved over the past week

McPherson's CEO Change